{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:39:49Z","timestamp":1785253189997,"version":"3.55.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.semnephrol.2025.151660","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T19:48:25Z","timestamp":1752781705000},"page":"151660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond Kidney Genes: Broad Clinical Implications of Genetic Testing for Nephrology Patients"],"prefix":"10.1016","volume":"45","author":[{"given":"Naama","family":"Elefant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Maras\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Milo Rasouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2025.151660_bib0001","article-title":"Navigating genetic testing in nephrology: options and decision-making strategies","author":"Groopman","year":"2024","journal-title":"Kidney Int Reports"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0002","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1073\/pnas.1909378117","article-title":"Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging","volume":"117","author":"Hou","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0003","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1073\/pnas.1706096114","article-title":"Precision medicine screening using whole-genome sequencing and advanced imaging to identify disease risk in adults","volume":"115","author":"Perkins","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0004","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1681\/ASN.0000000000000249","article-title":"The clinical utility of genetic testing in the diagnosis and management of adults with chronic kidney disease","volume":"34","author":"Dahl","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ndt\/gfab218","article-title":"Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice","volume":"37","author":"Knoers","year":"2022","journal-title":"Nephrol Dialysis Transplant"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0006","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.kint.2017.06.013","article-title":"Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders","volume":"92","author":"Mallett","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0007","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2215\/CJN.02730218","article-title":"Clinical pharmacogenomics: applications in nephrology","volume":"13","author":"Adams","year":"2018","journal-title":"CJASN"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0008","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41581-024-00886-2","article-title":"Polygenic scores and their applications in kidney disease","volume":"21","author":"Khan","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0009","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1681\/ASN.2016101108","article-title":"Genomic disorders and neurocognitive impairment in pediatric CKD","volume":"28","author":"Verbitsky","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1681\/ASN.2022060725","article-title":"Genomic disorders in CKD across the lifespan","volume":"34","author":"Verbitsky","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0011","article-title":"Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0012","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2024.05.010","article-title":"Advancing genetic testing in kidney diseases: report from a National Kidney Foundation Working Group","author":"Franceschini","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0013","doi-asserted-by":"crossref","DOI":"10.34067\/KID.0000000825","article-title":"The art and science of genetic counseling in nephrology","author":"Bogyo","year":"2025","journal-title":"Kidney360"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0014","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ndt\/gfz173","article-title":"Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases","volume":"36","author":"Mansilla","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0015","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41436-020-0772-y","article-title":"Initial experience from a renal genetics clinic demonstrates a distinct role in patient management","volume":"22","author":"Thomas","year":"2020","journal-title":"Genet Med."},{"key":"10.1016\/j.semnephrol.2025.151660_bib0016","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1681\/ASN.2018060575","article-title":"Whole-exome sequencing enables a precision medicine approach for kidney transplant recipients","volume":"30","author":"Mann","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0017","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ekir.2023.05.021","article-title":"Implementation and feasibility of clinical genome sequencing embedded into the outpatient nephrology care for patients with proteinuric kidney disease","volume":"8","author":"Marasa","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0018","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jgc4.1364","article-title":"GeneLiFT: a novel test to facilitate rapid screening of genetic literacy in a diverse population undergoing genetic testing","volume":"30","author":"Milo Rasouly","year":"2021","journal-title":"J Genet Couns."},{"key":"10.1016\/j.semnephrol.2025.151660_bib0019","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1038\/s41598-020-60215-y","article-title":"Comparison of Mendeliome exome capture kits for use in clinical diagnostics","volume":"10","author":"Pengelly","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0020","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41588-019-0528-2","article-title":"PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels","volume":"51","author":"Martin","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41581-024-00900-7","article-title":"A guide to gene-disease relationships in nephrology","volume":"21","author":"Stark","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0022","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.kint.2018.02.027","article-title":"A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases","volume":"94","author":"Bullich","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0023","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.2024.2667","article-title":"APOL1-mediated Kidney Disease","volume":"331","author":"Hopper","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0024","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa2202396","article-title":"Inaxaplin for proteinuric kidney disease in persons with two APOL1 variants","volume":"388","author":"Egbuna","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0025","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1038\/s41598-019-40761-w","article-title":"PKD1 duplicated regions limit clinical utility of whole exome sequencing for genetic diagnosis of autosomal dominant polycystic kidney disease","volume":"9","author":"Ali","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0026","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ajhg.2019.07.011","article-title":"Mendelian gene discovery: fast and furious with no end in sight","volume":"105","author":"Bamshad","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100947","article-title":"The landscape of reported VUS in multi-gene panel and genomic testing: time for a change","volume":"25","author":"Rehm","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0028","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ajhg.2024.03.008","article-title":"Exome copy number variant detection, analysis, and classification in a large cohort of families with undiagnosed rare genetic disease","volume":"111","author":"Lemire","year":"2024","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0029","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic utility of exome sequencing for kidney disease","volume":"380","author":"Groopman","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1750-1172-9-98","article-title":"The prevalence and epidemiology of genetic renal disease amongst adults with chronic kidney disease in Australia","volume":"9","author":"Mallett","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0031","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41525-022-00295-z","article-title":"Best practices for the interpretation and reporting of clinical whole genome sequencing","volume":"7","author":"Austin-Tse","year":"2022","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100866","article-title":"ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Miller","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0033","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/mgg3.283","article-title":"Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients","volume":"5","author":"Cousin","year":"2017","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0034","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1373\/clinchem.2014.231456","article-title":"Clinical exome performance for reporting secondary genetic findings","volume":"61","author":"Park","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0035","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/gim.2018.41","article-title":"Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing","volume":"20","author":"Alfares","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100006","article-title":"Returning integrated genomic risk and clinical recommendations: the eMERGE study","volume":"25","author":"Linder","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0037","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/humu.23643","article-title":"Scaling resolution of variant classification differences in ClinVar between 41 clinical laboratories through an outlier approach","volume":"39","author":"Harrison","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0038","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ajmg.c.31931","article-title":"Biased pathogenic assertions of loss of function variants challenge molecular diagnosis of admixed individuals","volume":"187","author":"Naslavsky","year":"2021","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0039","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.39571","article-title":"Rates and classification of variants of uncertain significance in hereditary disease genetic testing","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100880","article-title":"Molecular diagnostic yield of genome sequencing versus targeted gene panel testing in racially and ethnically diverse pediatric patients","volume":"25","author":"Abul-Husn","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0042","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10689-019-00144-6","article-title":"Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European","volume":"18","author":"Ndugga-Kabuye","year":"2019","journal-title":"Fam Cancer"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0043","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41436-020-0810-9","article-title":"Frequency of genomic secondary findings among 21,915 eMERGE network participants","volume":"22","year":"2020","journal-title":"Genetics Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2022.01.585","article-title":"OP037: Assessing the impact of expanded ACMG secondary findings recommendations on population genomic screening in the Geisinger MyCode Community Health Initiative","volume":"24","author":"Kelly","year":"2022","journal-title":"Genetics Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0045","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.3399\/bjgp20X714125","article-title":"Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care","volume":"71","author":"MacRae","year":"2021","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0046","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038401","article-title":"Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"10","author":"Sullivan","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0047","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0048","doi-asserted-by":"crossref","DOI":"10.1177\/20420188241252309","article-title":"Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor","volume":"15","author":"Lin","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0049","first-page":"253","article-title":"Chronic kidney disease and cancer: a troubling connection","volume":"23","author":"Stengel","year":"2010","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ecl.2024.11.001","article-title":"Management of obesity-related genetic disorders","volume":"54","author":"Esbati","year":"2025","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0051","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.kint.2024.02.021","article-title":"Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients","volume":"106","author":"Ma","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0052","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","article-title":"Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease","volume":"18","author":"Matsushita","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0053","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/gim.2014.151","article-title":"ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing","volume":"17","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0054","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41588-021-01011-w","article-title":"Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank","volume":"54","author":"Jurgens","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0055","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.mayocp.2024.05.027","article-title":"Prevalence, penetrance, and phenotypic manifestation of cardiomyopathy-associated genetic variants in the general population: insights from a Mayo Clinic Biobank Study","volume":"99","author":"Figueiral","year":"2024","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0056","article-title":"Prevalence and phenotypic burden of monogenic arrhythmias using integration of electronic health records with genetics","volume":"15","author":"Nafissi","year":"2022","journal-title":"Genomic Precision Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0057","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jacc.2020.06.037","article-title":"Identification of undetected monogenic cardiovascular disorders","volume":"76","author":"Abdulrahim","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0058","doi-asserted-by":"crossref","DOI":"10.1161\/HCG.0000000000000067","article-title":"Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association","volume":"13","author":"Musunuru","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0060","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.nefro.2024.05.001","article-title":"Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment: an opportunity for the nephrology","volume":"44","author":"Cases","year":"2024","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0059","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/joim.13355","article-title":"Association of the metabolic syndrome with mortality and major adverse cardiac events: a large chronic kidney disease cohort","volume":"290","author":"Pammer","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2024.12.021","article-title":"The prevention and management of chronic kidney disease among patients with metabolic syndrome","author":"Zhu","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0062","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2019.02.024","article-title":"The genetic basis of metabolic disease","volume":"177","author":"Barroso","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0063","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1038\/s41467-021-23556-4","article-title":"Determinants of penetrance and variable expressivity in monogenic metabolic conditions across 77,184 exomes","volume":"12","author":"Goodrich","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0064","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jimd.12348","article-title":"An international classification of inherited metabolic disorders (ICIMD)","volume":"44","author":"Ferreira","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.840797","article-title":"Familial hypercholesterolemia prevalence among ethnicities: systematic review and meta-analysis","volume":"13","author":"Toft-Nielsen","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.574474","article-title":"Genetics of familial hypercholesterolemia: new insights","volume":"11","author":"Vrablik","year":"2020","journal-title":". Front Genet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0067","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/healthcare4010014","article-title":"Expert and advocacy group consensus findings on the horizon of public health genetic testing","volume":"4","author":"Modell","year":"2016","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0068","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11883-023-01094-2","article-title":"Genetic testing for familial hypercholesterolemia in clinical practice","volume":"25","author":"Tricou","year":"2023","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0069","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00125-008-0942-y","article-title":"European Molecular Genetics Quality Network (EMQN) MODY group: best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young","volume":"51","author":"Ellard","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0070","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1681\/ASN.0000000000000199","article-title":"The crosstalk between nephropathy and coagulation disorder: pathogenesis, treatment, and dilemmas","volume":"34","author":"Qiu","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0071","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors\u2019 Organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"Mumford","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0072","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2023-177658","article-title":"Pre-operative coagulation test results do not correlate with self-bleeding assessment tool (Self-BAT) scores","volume":"142","author":"Tang","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0073","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1213\/ANE.0000000000006483","article-title":"Complications of Factor V Leiden in adults undergoing noncardiac surgical procedures: a systematic review","volume":"137","author":"Au","year":"2023","journal-title":"Anesth Analg"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0074","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0075","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2147\/JBM.S266791","article-title":"Why is misdiagnosis of von Willebrand disease still prevalent and how can we overcome it? A focus on clinical considerations and recommendations","volume":"12","author":"Colonne","year":"2021","journal-title":"J Blood Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0076","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/jth.14479","article-title":"Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: communication from the SSC of the ISTH","volume":"17","author":"Megy","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0077","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1038\/s41598-020-61144-6","article-title":"Stratified risks of infection-related hospitalization in patients with chronic kidney disease: a prospective cohort study","volume":"10","author":"Yang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0078","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2215\/CJN.05900420","article-title":"Infection-related acute care events among patients with glomerular disease","volume":"15","author":"Glenn","year":"2020","journal-title":"CJASN"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0079","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13223-023-00862-8","article-title":"Inborn errors of immunity in adulthood","volume":"20","author":"Wang","year":"2024","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0081","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.clim.2011.10.001","article-title":"Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency","volume":"142","author":"Shimizu","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0082","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00467-022-05656-5","article-title":"A rare cause of nephrotic syndrome-sphingosine-1-phosphate lyase (SGPL1) deficiency: 6 cases and a review of the literature","volume":"38","author":"Tastemel Ozturk","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0083","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12016-022-08933-1","article-title":"Diagnostic modalities in primary immunodeficiency","volume":"63","author":"Raymond","year":"2022","journal-title":"Clinic Rev Allerg Immunol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0084","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/ndt\/gfac337","article-title":"Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis","volume":"38","author":"Massicotte-Azarniouch","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ckj\/sfx122","article-title":"Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network","volume":"11","author":"Sprangers","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0086","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/TP.0000000000002931","article-title":"Recipient comorbidity and survival outcomes after kidney transplantation: a UK-wide prospective cohort study","volume":"104","author":"Wu","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0087","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.transproceed.2018.01.044","article-title":"Comorbidities can predict mortality of kidney transplant recipients: comparison with the Charlson Comorbidity Index","volume":"50","author":"Park","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0088","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13073-018-0607-5","article-title":"Prevalence of pathogenic\/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls","volume":"10","author":"Kim","year":"2018","journal-title":"Genome Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0089","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/gim.2017.145","article-title":"Early cancer diagnoses through BRCA1\/2 screening of unselected adult biobank participants","volume":"20","author":"Buchanan","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0090","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jnci\/dju379","article-title":"Population testing for cancer predisposing BRCA1\/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial","volume":"107","author":"Manchanda","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0091","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1158\/1055-9965.EPI-16-0693","article-title":"Prevalence and penetrance of major genes and polygenes for colorectal cancer","volume":"26","author":"Win","year":"2017","journal-title":"Cancer Epidemiol Biomark Prevent"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0092","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41436-019-0633-8","article-title":"A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients","volume":"22","author":"LaDuca","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0093","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","article-title":"NCCN Guidelines\u00ae Insights: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024","volume":"21","author":"Daly","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0094","doi-asserted-by":"crossref","first-page":"695","DOI":"10.6004\/jnccn.2024.0061","article-title":"Genetic\/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Hodan","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0095","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41576-022-00572-8","article-title":"Pharmacogenomics: current status and future perspectives","volume":"24","author":"Pirmohamed","year":"2023","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0096","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.3390\/ijms22094480","article-title":"A systematic review and meta-analysis of pharmacogenetic studies in patients with chronic kidney disease","volume":"22","author":"Tziastoudi","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0097","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/FTD.0000000000001289","article-title":"Customizing tacrolimus dosing in kidney transplantation: focus on pharmacogenetics","volume":"47","author":"Lloberas","year":"2025","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0098","article-title":"Implementation of a renal precision medicine program: clinician attitudes and acceptance","volume":"10","author":"Spiech","year":"2020","journal-title":"Life (Basel)"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0099","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/bcpt.13985","article-title":"Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: perspectives for prescribing optimization","volume":"134","author":"Westergaard","year":"2024","journal-title":"Basic Clin Pharma Tox"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cpt.113","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing","volume":"98","author":"Birdwell","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0126","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cpt.113","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing","volume":"98","author":"Birdwell","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0127","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/cpt.2557","article-title":"The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and statin-associated musculoskeletal symptoms","volume":"111","author":"Cooper-DeHoff","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0128","unstructured":"CPIC guideline for statins. Accessed from https:\/\/cpicpgx.org\/guidelines\/cpic-guideline-for-statins\/"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0129","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/clpt.2011.185","article-title":"Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing","volume":"90","author":"Johnson","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cpt.668","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for pharmacogenetics-guided warfarin dosing: 2017 update","volume":"102","author":"Johnson","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0131","unstructured":"CPIC guideline for warfarin and CYP2C9 and VKORC1. Accessed from https:\/\/cpicpgx.org\/guidelines\/guideline-for-warfarin-and-cyp2c9-and-vkorc1\/"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0132","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cpt.1830","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and nonsteroidal anti-inflammatory drugs","volume":"108","author":"Theken","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0133","unstructured":"CPIC guideline for NSAIDS based on CYP2C9 genotype. Accessed from https:\/\/cpicpgx.org\/guidelines\/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype\/"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0134","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/clpt.2011.132","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy","volume":"90","author":"Scott","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/clpt.2013.105","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update","volume":"94","author":"Scott","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0136","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/cpt.2526","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 genotype and clopidogrel therapy: 2022 update","volume":"112","author":"Lee","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0137","unstructured":"CPIC guideline for clopidogrel and CYP2C19. Accessed from https:\/\/cpicpgx.org\/guidelines\/guideline-for-clopidogrel-and-cyp2c19\/"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0138","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/cpt.2735","article-title":"Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for medication use in the context of G6PD genotype","volume":"113","author":"Gammal","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0139","unstructured":"CPIC guideline for G6PD. Accessed from https:\/\/cpicpgx.org\/guidelines\/cpic-guideline-for-g6pd\/"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00702-018-1922-0","article-title":"An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes","volume":"126","author":"Mostafa","year":"2019","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0101","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/clpt.2013.229","article-title":"Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing","volume":"95","author":"Van Driest","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0102","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41398-021-01417-4","article-title":"Pharmacogenetic genotype and phenotype frequencies in a large Danish population-based case-cohort sample","volume":"11","author":"Lunenburg","year":"2021","journal-title":"Transl Psychiatr"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0103","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/cpt.350","article-title":"Genetic variation among 82 pharmacogenes: the PGRNseq data from the eMERGE network","volume":"100","author":"Bush","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0104","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.948616","article-title":"Comprehensive characterization of pharmacogenes in a Taiwanese Han population","volume":"13","author":"Lu","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0105","first-page":"6","article-title":"ADME gene-related pharmacogenomic labeling of FDA-approved drugs: comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) evidence levels","volume":"11","author":"Deb","year":"2024","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0106","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/cpt.2350","article-title":"An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine","volume":"110","author":"Whirl-Carrillo","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0107","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/clpt.2010.279","article-title":"CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network","volume":"89","author":"Relling","year":"2011","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.semnephrol.2025.151660_bib0108","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1389200215666140130124910","article-title":"Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process","volume":"15","author":"Caudle","year":"2014","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0109","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cpt.1651","article-title":"The Clinical Pharmacogenetics Implementation Consortium: 10 years later","volume":"107","author":"Relling","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0110","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41431-023-01347-3","article-title":"Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics","volume":"32","author":"Beunk","year":"2024","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0111","article-title":"Pharmacogenetics guidelines: overview and comparison of the DPWG, CPIC, CPNDS, and RNPGx guidelines","volume":"11","author":"Abdullah-Koolmees","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0112","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/jac5.1699","article-title":"How to implement a pharmacogenetics service at your institution","volume":"5","author":"Cicali","year":"2022","journal-title":"J Am Coll Clin Pharm"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0113","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1038\/s41436-019-0500-7","article-title":"Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings","volume":"21","author":"Cicali","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0114","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajhg.2025.03.003","article-title":"Low-cost generation of clinical-grade, layperson-friendly pharmacogenetic passports using oligonucleotide arrays","author":"Lanting","year":"2025","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164972","article-title":"Incidence of exposure of patients in the United States to multiple drugs for which pharmacogenomic guidelines are available","volume":"11","author":"Samwald","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0116","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41397-024-00326-1","article-title":"A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care","volume":"24","author":"Chenchula","year":"2024","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0117","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/cpt.2754","article-title":"Cost effectiveness of pharmacogenetic testing for drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines: a systematic review","volume":"112","author":"Morris","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0118","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(22)01841-4","article-title":"A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study","volume":"401","author":"Swen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0119","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1458095","article-title":"Integration of pharmacogenetic data in epic genomic module drives clinical decision support alerts","volume":"15","author":"Newsom","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0120","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/cpt.3599","article-title":"Implementing pharmacogenomics clinical decision support: a comprehensive tutorial on how to integrate the epic genomics module","volume":"117","author":"Hall","year":"2025","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0121","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/jpm11050394","article-title":"Implementing pharmacogenomics testing: single center experience at Arkansas Children\u2019s Hospital","volume":"11","author":"Gill","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0122","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/jamia\/ocae293","article-title":"Clinical implementation of preemptive pharmacogenomics testing for personalized medicine at an academic medical center","volume":"32","author":"Tamraz","year":"2025","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.gimo.2023.100779","article-title":"Customizing the electronic health record for delivery of pharmacogenetics","volume":"1","author":"Hoffecker","year":"2023","journal-title":"Genetics Med Open"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0124","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jamia\/ocz177","article-title":"Integrating pharmacogenomics into the electronic health record by implementing genomic indicators","volume":"27","author":"Caraballo","year":"2020","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0140","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1681\/ASN.2014080837","article-title":"Utility of HLA antibody testing in kidney transplantation","volume":"26","author":"Konvalinka","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0141","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5500\/wjt.v7.i6.339","article-title":"Human leukocyte antigen typing and crossmatch: a comprehensive review","volume":"7","author":"Althaf","year":"2017","journal-title":"World J Transplant"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0142","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.4238\/2014.April.8.9","article-title":"HLA-B35, a common genetic trait, in a familial case of Henoch-Schoenlein purpura and Berger\u2019s disease","volume":"13","author":"Pellegrin","year":"2014","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0143","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1681\/ASN.2013050446","article-title":"Lupus nephritis susceptibility loci in women with systemic lupus erythematosus","volume":"25","author":"Chung","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0144","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ACI.0000000000000286","article-title":"Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions","volume":"16","author":"Wang","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0145","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaci.2015.03.019","article-title":"Pharmacogenetics of abacavir hypersensitivity: a systematic review and meta-analysis of the association with HLA-B*57:01","volume":"136","author":"Sousa-Pinto","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0146","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev-biodatasci-111721-074830","article-title":"Challenges and opportunities for developing more generalizable polygenic risk scores","volume":"5","author":"Wang","year":"2022","journal-title":"Annu Rev Biomed Data Sci"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0147","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCGEN.122.003834","article-title":"Current state and future of polygenic risk scores in cardiometabolic disease: a scoping review","volume":"16","author":"Phulka","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0148","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41591-023-02429-x","article-title":"A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease","volume":"29","author":"Patel","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0149","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.123.004272","article-title":"Multi-ancestry polygenic risk score for coronary heart disease based on an ancestrally diverse genome-wide association study and population-specific optimization","volume":"17","author":"Smith","year":"2024","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0150","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/cancers17071056","article-title":"Guidance for the clinical use of the breast cancer polygenic risk scores","volume":"17","author":"Padrik","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0151","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa2407934","article-title":"Assessment of a polygenic risk score in screening for prostate cancer","volume":"392","author":"McHugh","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0152","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63584","article-title":"Taking the risk: a systematic review of ethical reasons and moral arguments in the clinical use of polygenic risk scores","volume":"194","author":"Andreoli","year":"2024","journal-title":"Am J Med Genetics A"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0153","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41576-023-00637-2","article-title":"Principles and methods for transferring polygenic risk scores across global populations","volume":"25","author":"Kachuri","year":"2024","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0154","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1038\/s41467-023-43878-9","article-title":"Polygenic risk alters the penetrance of monogenic kidney disease","volume":"14","author":"Khan","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0155","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/jpm13040573","article-title":"Polygenic scores in the direct-to-consumer setting: challenges and opportunities for a new era in consumer genetic testing","volume":"13","author":"Park","year":"2023","journal-title":"J Pers Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0156","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1681\/ASN.2022030262","article-title":"Clonal hematopoiesis and CKD progression","volume":"33","author":"Niroula","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0157","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.0000000739","article-title":"Deciphering clonal hematopoiesis of indeterminate potential: methods, mechanisms, and implications for kidney diseases","author":"Yu","year":"2025","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2025.151660_bib0158","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s44313-025-00065-7","article-title":"Clonal hematopoiesis: elements associated with clonal expansion and diseases","volume":"60","author":"Ryu","year":"2025","journal-title":"Blood Res"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0159","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12979-022-00278-9","article-title":"Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics","volume":"19","author":"Uddin","year":"2022","journal-title":"Immun Ageing"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00395-022-00969-w","article-title":"Clonal hematopoiesis and cardiovascular disease: deciphering interconnections","volume":"117","author":"Stein","year":"2022","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0161","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/bloodadvances.2019000394","article-title":"Stem cell donors should be screened for CHIP","volume":"4","author":"DeZern","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0162","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1158\/1078-0432.CCR-22-2598","article-title":"CHIP happens: clonal hematopoiesis of indeterminate potential and its relationship to solid tumors","volume":"29","author":"Reed","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0163","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.3390\/jcm9082480","article-title":"Translating evidence from clonal hematopoiesis to cardiovascular disease: a systematic review","volume":"9","author":"Papa","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0164","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0165","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1681\/ASN.2021060774","article-title":"Association of clonal hematopoiesis of indeterminate potential with worse kidney function and anemia in two cohorts of patients with advanced chronic kidney disease","volume":"33","author":"Vlasschaert","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0166","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41591-024-02854-6","article-title":"Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury","volume":"30","author":"Vlasschaert","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0167","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10897-005-9014-3","article-title":"A new definition of genetic counseling: National Society of Genetic Counselors\u2019 Task Force report","volume":"15","author":"R","year":"2006","journal-title":"J Genet Couns"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0168","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100668","article-title":"Genetic counseling in kidney disease: a perspective","volume":"5","author":"Stein","year":"2023","journal-title":"Kidney Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0169","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jgc4.1511","article-title":"Do research participants share genomic screening results with family members?","volume":"31","author":"Wynn","year":"2022","journal-title":"J Genet Couns"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0170","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tig.2017.02.002","article-title":"Comparative approaches to genetic discrimination: chasing shadows?","volume":"33","author":"Joly","year":"2017","journal-title":"Trends Genet"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0171","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41525-021-00218-4","article-title":"Genetic discrimination: introducing the Asian perspective to the debate","volume":"6","author":"Kim","year":"2021","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0172","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajt.2024.10.019","article-title":"Evaluation for genetic disease in kidney transplant candidates: a practice resource","volume":"25","author":"Ames","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0173","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jgc4.1386","article-title":"Genetic counseling for patients with positive genomic screening results: considerations for when the genetic test comes first","volume":"30","author":"Schwartz","year":"2021","journal-title":"J Genet Couns"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0174","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.2023.4387","article-title":"It takes an average of 17 years for evidence to change practice: the burgeoning field of implementation science seeks to speed things up","volume":"329","author":"Rubin","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0175","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2022.961128","article-title":"EDGE Study Team: barriers, interventions, and recommendations: improving the genetic testing landscape","volume":"4","author":"Dusic","year":"2022","journal-title":"Front Digit Health"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0177","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s41436-019-0502-5","article-title":"The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"21","year":"2019","journal-title":"Genetics Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0178","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100814","article-title":"The effect of genetic education on the referral of patients to genetic evaluation: findings from a national survey of nephrologists","volume":"25","author":"Rasouly","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0179","first-page":"165","article-title":"Clinical genetic testing in medical education","volume":"32","author":"Kopel","year":"2019","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.semnephrol.2025.151660_bib0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jgc4.1795","article-title":"Poor recall of genetics curriculum by medical students highlights barriers to use in clinical practice","volume":"33","author":"Kapur","year":"2024","journal-title":"J Genetic Counsel"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T14:43:24Z","timestamp":1754664204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929525000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":179,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0270929525000981"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151660","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond Kidney Genes: Broad Clinical Implications of Genetic Testing for Nephrology Patients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151660"}}